Paroxysmal Cold Hemoglobinuria Overview

Save information for later
Sign Up

Learn About Paroxysmal Cold Hemoglobinuria

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Paroxysmal Cold Hemoglobinuria Local Doctors?
Jaroslaw Maciejewski
Elite in Paroxysmal Cold Hemoglobinuria
Elite in Paroxysmal Cold Hemoglobinuria

Cleveland Clinic

8950 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English
Offers Telehealth

Jaroslaw Maciejewski is a Hematologist in Cleveland, Ohio. Dr. Maciejewski is rated as an Elite provider by MediFind in the treatment of Paroxysmal Cold Hemoglobinuria. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Paroxysmal Cold Hemoglobinuria, Bone Marrow Transplant, and Splenectomy.

Phillip A. Scheinberg
Elite in Paroxysmal Cold Hemoglobinuria
Hematology Oncology
Elite in Paroxysmal Cold Hemoglobinuria
Hematology Oncology
10 Center Dr, Bldg 10 Crc, Rm 3-5140, 
Bethesda, MD 
Languages Spoken:
English

Phillip Scheinberg is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Scheinberg is rated as an Elite provider by MediFind in the treatment of Paroxysmal Cold Hemoglobinuria. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Shinji Nakao
Elite in Paroxysmal Cold Hemoglobinuria
Elite in Paroxysmal Cold Hemoglobinuria
Kanazawa, JP 

Shinji Nakao practices in Kanazawa, Japan. Mr. Nakao is rated as an Elite expert by MediFind in the treatment of Paroxysmal Cold Hemoglobinuria. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Cold Hemoglobinuria, Bone Marrow Transplant, and Tissue Biopsy.

What are the latest Paroxysmal Cold Hemoglobinuria Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open-label, Single-arm, Multicenter, Phase 3 Study to Assess Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric PNH Patients 2 to <18 Years of Age

Summary: The purpose of this open-label, single arm, multicenter, phase 3 study is to assess the pharmacokinetics of iptacopan in pediatric patients and to assess whether iptacopan is safe and well tolerated when used for the treatment of pediatric paroxysmal nocturnal hemoglobinuria (PNH) patients 2 to \< 18 years of age.